Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mosaic Immunoengineering (CPMV)

Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,904
  • Shares Outstanding, K 7,242
  • Annual Sales, $ 0 K
  • Annual Income, $ -920 K
  • EBIT $ -1 M
  • EBITDA $ -1 M
  • 60-Month Beta -0.76
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings $-0.02 on 11/19/25
  • Next Earnings Date 04/21/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend 0.020 on 02/22/06
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3140 +124.11%
on 02/09/26
0.7450 -5.54%
on 02/25/26
+0.0557 (+8.60%)
since 01/21/26
3-Month
0.3100 +127.00%
on 12/31/25
0.7450 -5.54%
on 02/25/26
+0.1037 (+17.28%)
since 11/13/25
52-Week
0.2520 +179.25%
on 06/03/25
1.0500 -32.98%
on 10/17/25
-0.2763 (-28.19%)
since 02/20/25

Most Recent Stories

More News
Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

CPMV : 0.7037 (+75.49%)
Newly Published Data Further Support Mosaic ImmunoEngineering’s Lead Immuno-Oncology Candidate MIE-101 in Combination with OX40 Checkpoint Treatment in Melanoma

- Broad, durable, and systemic anti-tumor immunity observed using inCPMV with OX40 agonist antibodies - Intratumoral inCPMV administration in combination with systemic anti-OX40 controlled the progression...

CPMV : 0.7037 (+75.49%)
Mosaic ImmunoEngineering's Lead Immuno-Oncology Candidate MIE-101 Highlighted in Keynote Presentation

- Nanoparticle technology shown to be effective in transforming immunologically "cold" tumors to "hot" - - Data presented support durable antitumor activity - NOVATO, CA / ACCESSWIRE / November 1, 2021...

CPMV : 0.7037 (+75.49%)
Mosaic ImmunoEngineering Announces Upcoming Presentation at the 23rd Annual SoCalBio Conference

Presentation to highlight Mosaic's naturally-derived immuno-oncology candidate, MIE-101 Intratumoral administration of MIE-101 activates immune cells to initiate potent, systemic and durable antitumor...

CPMV : 0.7037 (+75.49%)
Spotlight Presentation at the World Molecular Imaging Congress Highlights Mosaic ImmunoEngineering's Immuno-Oncology and Modular Vaccine Platform Candidates

- Presentation detailed the Company's COVID-19 vaccine candidates that generated antibodies that neutralized SARS-CoV-2 infection of human cells - Vaccine candidates hold potential for rapid response to...

CPMV : 0.7037 (+75.49%)
Mosaic ImmunoEngineering Expands Immuno-Oncology Platform Through New Technology Licensing Agreement with the University of California San Diego

- Nanoparticle-based technology complements the company's intratumoral technology platform - NOVATO, CA / ACCESSWIRE / October 6, 2021 / Mosaic ImmunoEngineering, Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV),...

CPMV : 0.7037 (+75.49%)
Upcoming Presentation at the World Molecular Imaging Congress to Highlight Mosaic ImmunoEngineering’s Lead Immuno-Oncology and Modular Vaccine Platform COVID-19 Vaccine Candidates

NOVATO, CA / ACCESSWIRE / October 1, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and engineering...

CPMV : 0.7037 (+75.49%)
Upcoming Presentation at the World Molecular Imaging Congress to Highlight Mosaic ImmunoEngineering’s Lead Immuno-Oncology and Modular Vaccine Platform COVID-19 Vaccine Candidates

NOVATO, CA / ACCESSWIRE / October 1, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and engineering...

CPMV : 0.7037 (+75.49%)
Mosaic ImmunoEngineering Announces Keynote Presentation Highlighting its Modular Vaccine Platform Delivery Technology

- Presentation highlighted potential of polymer-based delivery system for slow-release of vaccines that potentially require no booster shots - - Delivery system is transportation and storage friendly with...

CPMV : 0.7037 (+75.49%)
Mosaic ImmunoEngineering Announces Publication of Data Supporting the Potential of Its SARS-CoV-2 Vaccine Candidates under its Modular Vaccine Platform

Vaccine candidates triggered high production of neutralizing antibodies against SARS-CoV-2 and SARS-CoV-1 in preclinical studies Epitopes used in the vaccine candidates are located in regions that are...

CPMV : 0.7037 (+75.49%)

Business Summary

Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. It is focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. The company's product pipeline includes MI-O-101. Mosaic ImmunoEngineering Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 0.7725
2nd Resistance Point 0.7588
1st Resistance Point 0.7312
Last Price 0.7037
1st Support Level 0.6899
2nd Support Level 0.6762
3rd Support Level 0.6486

See More

52-Week High 1.0500
Fibonacci 61.8% 0.7452
Last Price 0.7037
Fibonacci 50% 0.6510
Fibonacci 38.2% 0.5568
52-Week Low 0.2520

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar